The healthcare community is intently watching the novel dual-action agent, a dual-action therapy targeting both glucose metabolism and another key signal. Initial trials suggest it may offer meaningful benefits in obesity management compared to current medications, potentially representing a major step forward in the fight of obesity. More inves… Read More